"False"
Skip to content
printicon
Main menu hidden.

UCMR - Umeå Centre for Microbial Research

UCMR is a national Linnaeus Center of Excellence at Umeå University that promotes interdisciplinary cutting-edge microbial and translational research. The latest groundbreaking discovery is Emmanuelle Charpentier's work on the CRISPR-Cas9 mechanism, for which she was awarded the 2020 Nobel Prize in Chemistry.

UCMR history

Milestones in the history of UCMR.

ledningsgruppen UCMR: Ingrid Söderbergh, Marta Bally och Fredrik Almqvist
Management team

Welcome to contact us!

Excellence, Interdisciplinarity, Collaboration

UCMR is located at Umeå University, the flagship university in Northern Sweden. It is an interdisciplinary consortium of academic research groups with outstanding track records in the fields of microbial pathogenesis, molecular and cell biology, chemistry, clinical microbiology, structural biology, immunology, epidemiology, microbial ecology, physics, mathematics, and data-driven science.

Together, with joined forces UCMR is establishing a world-leading and sustainable science environment promoting cutting-edge molecular and translational microbial research at Umeå University. As of today, 67 Principal Investigators and their research groups are affiliated to UCMR.

The recent ground-breaking discovery is Emmanuelle Charpentier’s seminal work of the CRISPR-Cas9 mechanism, for which she was awarded Nobel Prize in Chemistry in 2020. When the discovery was made, Emmanuelle Charpentier was active at Umeå University. She was one of the first recruited group leaders at the Laboratory for Molecular Infection Medicine Sweden (MIMS) sprung from UCMR.

"The jewel in the crown"

UCMR is a Swedish Linnaeus Centre of Excellence. In 2008 the consortium was awarded a 10-year grant from the Swedish Research Council. In 2020 the 40 different Centers of Excellence within the Linnaeus programme were evaluated by an international expert panel. UCMR was ranked among the top three in all three areas; research performance, societal relevance, and international competitiveness. The panel characterized UCMR as "the jewel in the crown".

The vision of UCMR

The vision of UCMR is to develop a world-leading science environment promoting cutting-edge molecular and translational research in microbial infection.

The way forward:

  • Conduct and develop high-quality research and education in molecular and translational infection research
  • Strengthen and develop a multidisciplinary research platform and promote new synergies and collaborations
  • Train the next-generation scientists and clinicians
  • Overcome societal challenges posed by microbial infectious diseases

MIMS

The Laboratory for Molecular Infection Medicine Sweden, MIMS, at Umeå University is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine. The centre is a close collaborator and a part of Umeå Centre for Microbial Research, UCMR.

Organisation

Pricipal investigators (PI)

67 active research groups are affiliated to UCMR.

Alumni PI

Research leaders who were previously UCMR PIs.

Executive Board

Clas Ahlm
Professor, senior consultant (attending) physician
E-mail
Email
Dan Andersson
Professor of Medical Bacteriology, Uppsala University
E-mail
Email
Birgitta Henriques Normark
Professor of Clinical Microbiology st , Karolinska Institutet
E-mail
Email
Ulf Nilsson
Professor at the Centre for Analysis and Synthesis, Lund University
E-mail
Email

Research Strategic Committee

Fredrik Almqvist
Professor, other position
E-mail
Email
Jennie Ekbeck
CEO, Umå Biotech Incubator
E-mail
Email
Johan Normark
Associate professor, consultant (attending) physician (on leave), associate professor, consultant (attending) physician, associate professor
E-mail
Email
Maria Fällman
Research fellow, professor
E-mail
Email

UCMR is supported by

Latest update: 2024-02-08